Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O9 antigen polysaccharide is a key surface component of the lipopolysaccharide (LPS) layer in Salmonella enterica serovar Enteritidis, a major cause of foodborne illness worldwide. The O-antigen is responsible for the serological specificity of this bacterium and plays an important role in immune recognition, virulence, and vaccine development. It consists of repeating oligosaccharide units (mannose, rhamnose, galactose, and tyvelose) forming the outermost part of LPS. It provides protection against host defenses, contributes to bacterial virulence, and is a prime target for diagnostic assays and vaccine development against non-typhoidal Salmonella infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Enteritidis O-antigen polysaccharide (O9).